Cann Group has acquired the license and distribution rights for CannaKorp Inc’s proprietary vaporising system as well as the right to produce the medicinal cannabis pods associated with the device.
CannaKorp is a Massachusetts-based technology start-up company that is simplifying and improving the inhalation process for medicinal cannabis patients. It has designed and developed vaporisation technology which incorporates a desktop vaporiser device that accepts single-use pods containing precisely prepared ground cannabis.
Cann is granted a license to import and sell the system in Australia and New Zealand, as well as manufacturing rights which includes an initial nine month exclusive right following regulatory approvals.
Source: 420 Intel – United States